AKU’s Centre for Regenerative Medicine and Stem Cell Research (CRM) is leveraging efforts to develop new, targeted therapies for a common form of blood cancer in adults, Philadelphia chromosome positive (Ph+) leukaemia. The aim is to understand the biology of the disease and use this knowledge to develop economically viable therapies. Being a part of the research team, Sujjawal Ahmad conveys his admiration.
The Aga Khan University –University of California, San Francisco (UCSF) partnership began a comprehensive and integrated research programme at AKU in stem cell biology and regenerative medicine. Since then, the Centre, under the leadership of Professor Dr El-Nasir M A Lalani , is creating a strong regenerative medicine and stem cell research community across AKU campuses by inducting and training a cadre of clinical researchers, preparing them to undertake ambitious research programmes under the highest ethical, scientific, and medical standards for alleviating disease and improving human health in a state-of-the-art research facility.
Learn more about the research center: https://www.aku.edu/crm/
Follow them on LinkedIn: https://www.linkedin.com/company/akucrm/
Learn more about Sujjawal and his work: https://www.aku.edu/crm/people